OXIS International to introduce new ergothioneine-based products for joint health and healthy aging

OXIS INTERNATIONAL, INC. (OTC Bulletin Board: OXIS, Paris: OXI) is proud to announce that it will introduce the benefits of Ergothioneine to the consumer market in September 2010 via breakthrough products for joint health and healthy aging.  The first products, ErgoFlex® and ErgoPlex®, will initially be marketed via a direct mail offering being developed in partnership with Creative Direct Marketing Group, the leading service provider in the direct mail sector of the direct to consumer channel.  

"These exciting new formulas provide a previously unavailable suite of benefits to the growing number of baby boomers and younger active lifestyle consumers seeking better solutions to combat the effects of aging in general and more specifically, joint pain," stated Bernie Landes, President of Oxis. "These products provide a unique blend of Ergothioneine and complementary and synergistic ingredients that treat aging and joint health as multidimensional complexes," he added. "By taking advantage of the unique functional benefits of Ergothioneine alone and as a co-factor with other key nutraceutical compounds, we believe that Oxis will be able to provide highly beneficial, proprietary solutions unavailable from any other products in the market today," Landes concluded.

With the introduction of these products, Oxis will stand alone as a supplier of Ergothioneine based products to the global market.  These initial products are part of a broad strategy to develop the growing market opportunities for proprietary new approaches to dietary supplement, functional food and beverage and personal care products.


OXIS International, Inc.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.